Skip to main content
. 2018 Nov 19;5(12):ofy300. doi: 10.1093/ofid/ofy300

Figure 1.

Figure 1.

Prevalence of the piperacillin-tazobactam-nonsusceptible/ceftriaxone-susceptible phenotype among Ec and Kp bloodstream isolates from 2011 to 2015.